Cardiovascular Systems () ROE US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2022 | LTM ? | CAGR 5 years ? | ||||
ROE, % | ? | -10.1% | -4.95% | 0.00% | -14 804% | -14.8% | -11.8% | ||
Changes by years, y/y, % | -10pp | +5pp | +5pp | +14 789pp | +57.8% |
Cardiovascular Systems. ROE, %
Cardiovascular Systems. ROE, changes, pp
Cardiovascular Systems () ROE US GAAP (quarter values) |
||||||||
2022Q4 | 2022Q4 | 2023Q1 | 2023Q1 | 2023Q2 | LTM ? | |||
ROE, % | ? | -14 935% | -18.8% | -11 983% | -16.4% | -19.9% | -11.8% | |
Changes by years, y/y, % | -14 930pp | -14pp | -11 968pp | -2pp | ||||
Changes by quarters, q/q, % | -14 920pp | +14 916pp | -11 964pp | +11 966pp | -3pp |